Sermorelin
GHRH 1-29 / GRF 1-29 / Geref
- Peptide length
- 29 amino acids
Amidated GHRH (1–29)
Open the sources to check how the studies were done and what they can support.
The amidated N-terminal fragment of human GHRH, with historical diagnostic and pediatric therapeutic use.
- Family
- GHRH fragment
- Research target
- GHRH receptor
- Molecular form
- Amidated GHRH (1–29)
What to know about the research
Historical product evidence does not establish adult anti-aging benefits or equivalence of a compounded formulation.
Check the exact compound
Sermorelin is not the substituted modified-GRF variant or DAC-conjugated CJC-1295. Check the exact peptide and terminal amidation.
What supports this entry?
The reference list is available. A statement-by-statement source check has not been completed for this entry.
These are selected references, not a complete review of the literature. Source checks were assisted by AI and have not received independent expert review.
Research stage, study quality and regulatory status answer different questions. A study card does not establish treatment benefit or approval.
No study details have been extracted for this exact entry yet. This does not mean that no studies exist. Open the references and check the exact material.
How we prepare and correct these entries